Startup Roche to acquire Good Therapeutics’ lead drug program for $250M, plus milestone payments – StartupSeptember 8, 20220 Seattle-based Good Therapeutics designs therapies that may be administered systemically for focused activation within the physique. (Good Therapeutics Graphic) Pharmaceutical…